BELLEVICINE, CLAUDIO
 Distribuzione geografica
Continente #
AS - Asia 6.155
NA - Nord America 5.584
EU - Europa 4.300
SA - Sud America 659
Continente sconosciuto - Info sul continente non disponibili 315
AF - Africa 143
OC - Oceania 5
Totale 17.161
Nazione #
US - Stati Uniti d'America 5.334
SG - Singapore 2.611
RU - Federazione Russa 2.017
VN - Vietnam 1.152
CN - Cina 1.127
IT - Italia 1.018
HK - Hong Kong 552
BR - Brasile 535
DE - Germania 294
FR - Francia 203
NL - Olanda 176
FI - Finlandia 153
BD - Bangladesh 143
CA - Canada 143
IN - India 143
GB - Regno Unito 103
IE - Irlanda 79
JP - Giappone 75
MX - Messico 57
KR - Corea 56
AR - Argentina 50
ES - Italia 44
PL - Polonia 43
PH - Filippine 38
ZA - Sudafrica 38
CI - Costa d'Avorio 37
IQ - Iraq 37
TH - Thailandia 37
UA - Ucraina 36
EC - Ecuador 27
ID - Indonesia 26
LT - Lituania 23
SE - Svezia 21
AT - Austria 20
TR - Turchia 19
EG - Egitto 17
PK - Pakistan 16
IR - Iran 15
JO - Giordania 13
TW - Taiwan 13
VE - Venezuela 13
CO - Colombia 11
UZ - Uzbekistan 11
DZ - Algeria 9
AE - Emirati Arabi Uniti 8
IL - Israele 8
RO - Romania 8
BE - Belgio 7
CR - Costa Rica 7
CZ - Repubblica Ceca 7
JM - Giamaica 7
KE - Kenya 7
MY - Malesia 7
RS - Serbia 7
SA - Arabia Saudita 7
AL - Albania 6
PE - Perù 6
PY - Paraguay 6
CL - Cile 5
ET - Etiopia 5
KZ - Kazakistan 5
MA - Marocco 5
SY - Repubblica araba siriana 5
TN - Tunisia 5
TT - Trinidad e Tobago 5
NI - Nicaragua 4
NP - Nepal 4
OM - Oman 4
PT - Portogallo 4
XK - ???statistics.table.value.countryCode.XK??? 4
AZ - Azerbaigian 3
EE - Estonia 3
GR - Grecia 3
HN - Honduras 3
LB - Libano 3
MN - Mongolia 3
NG - Nigeria 3
AD - Andorra 2
AU - Australia 2
BG - Bulgaria 2
BO - Bolivia 2
BS - Bahamas 2
BY - Bielorussia 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
EU - Europa 2
GD - Grenada 2
GE - Georgia 2
GN - Guinea 2
GT - Guatemala 2
HR - Croazia 2
HT - Haiti 2
HU - Ungheria 2
KG - Kirghizistan 2
KW - Kuwait 2
LV - Lettonia 2
NZ - Nuova Zelanda 2
PA - Panama 2
PR - Porto Rico 2
SI - Slovenia 2
Totale 16.805
Città #
Singapore 1.241
San Jose 1.158
Hong Kong 528
Moscow 493
Ashburn 475
Chandler 427
Beijing 343
Ho Chi Minh City 319
Hanoi 277
Naples 248
Santa Clara 172
Los Angeles 167
Hefei 166
The Dalles 150
Lauterbourg 139
Millbury 137
Amsterdam 128
Napoli 120
Munich 111
Des Moines 79
New York 76
Princeton 71
Boston 69
Tokyo 64
Nanjing 63
São Paulo 60
Redondo Beach 58
Buffalo 55
Lawrence 51
Rome 50
Dallas 49
Orem 48
Wilmington 48
Council Bluffs 47
Haiphong 47
Frankfurt am Main 45
Helsinki 44
Da Nang 43
Milan 43
Chicago 40
Montreal 39
Seoul 35
Warsaw 35
Atlanta 34
Turku 34
Kochi 33
Ottawa 32
Brooklyn 29
Biên Hòa 28
Seattle 28
Chennai 26
Nanchang 25
Rio de Janeiro 25
Mexico City 24
Toronto 24
Falkenstein 23
Nuremberg 23
London 22
Denver 21
Hebei 21
Houston 21
Johannesburg 19
San Giovanni Rotondo 19
Stockholm 18
Baghdad 17
Dong Ket 16
Poplar 16
Changsha 15
Hải Dương 15
Bangkok 14
Jiaxing 13
Lappeenranta 13
New Delhi 13
Phoenix 13
Salerno 13
Thái Nguyên 13
Amman 12
Can Tho 12
Falls Church 12
Redwood City 12
San Francisco 12
Tianjin 12
Belo Horizonte 11
Dublin 11
Cairo 10
Guayaquil 10
Philadelphia 10
Tashkent 10
Tehran 10
Valencia 10
Dhaka 9
Guangzhou 9
Pune 9
Salt Lake City 9
Shenyang 9
Vienna 9
Detroit 8
Düsseldorf 8
Fairfield 8
Jacksonville 8
Totale 8.998
Nome #
Performance analysis of SiRe next-generation sequencing panel in diagnostic setting: focus on NSCLC routine samples 225
Cell free DNA analysis by SiRe® next generation sequencing panel in non small cell lung cancer patients: focus on basal setting. 189
Thyroid Cancer and Fibroblasts 186
The Metallophosphoesterase-Domain-Containing Protein 2 (MPPED2) Gene Acts as Tumor Suppressor in Breast Cancer 184
Generation and analysis of spheroids from human primary skin myofibroblasts: an experimental system to study myofibroblasts deactivation 178
Development of a Stromal Microenvironment Experimental Model Containing Proto-Myofibroblast Like Cells and Analysis of Its Crosstalk with Melanoma Cells: A New Tool to Potentiate and Stabilize Tumor Suppressor Phenotype of Dermal Myofibroblasts 178
Type 2 Deiodinase Thr92Ala Polymorphism and Aging Are Associated with a Decreased Pituitary Sensitivity to Thyroid Hormone 177
Analysis of human primary fibroblast spheroids 177
EGFR mutations detected on cytology samples by a centralized laboratory reliably predict response to gefitinib in non-small cell lung carcinoma patients. 167
Impairment of T cell development and acute inflammatory response in HIV-1 Tat transgenic mice 166
Discordance in RAS mutations between primary colon tumor and metastases: a real event or a matter of methodology? 163
Different qualifiers of AUS/FLUS thyroid FNA have distinct BRAF, RAS, RET/PTC, and PAX8/PPARg alterations. 160
Predictive molecular pathology in metastatic thyroid cancer: the role of RET fusions 160
Rapid On-site Molecular Evaluation in thyroid cytopathology: A same-day cytological and molecular diagnosis 157
Cytopathology practice during the COVID-19 postlockdown: An Italian experience 157
SMO Gene Amplification and Activation of the Hedgehog Pathway as Novel Mechanisms of Resistance to Anti-Epidermal Growth Factor Receptor Drugs in Human Lung Cancer 156
Next generation sequencing techniques in liquid biopsy: focus on non-small cell lung cancer patients 156
Combination of Lenvatinib and Pembrolizumab as Salvage Treatment for Paucicellular Variant of Anaplastic Thyroid Cancer: A Case Report 156
Long-term management of lenvatinib-treated thyroid cancer patients: a real-life experience at a single institution 155
Potential involvement of neutrophils in human thyroid cancer 154
A Roadmap for a Comprehensive Diagnostic Approach to Fine Needle Cytology of Lymph Node Metastases 150
Ciliated foregut cyst of the pancreas: A benign lesion with elevated CEA levels 150
UbcH10 expression can predict prognosis and sensitivity to the antineoplastic treatment for colorectal cancer patients 150
PD-L1 expression in cell-blocks of non-small cell lung cancer: The impact of prolonged fixation 150
Evaluation of the Molecular Landscape in PD-L1 Positive Metastatic NSCLC: Data from Campania, Italy 149
Role of Cytomorphology in the Era of Liquid Biopsy 147
ALK and ROS1 testing on lung cancer cytologic samples: Perspectives 146
Foxe1 gene dosage affects thyroid cancer histology and differentiation in vivo 145
RNA-based next generation sequencing in non-small-cell lung cancer in a routine setting: an experience from an Italian referral center 144
PD-L1 expression on routine samples of non-small cell lung cancer: Results and critical issues from a 1-year experience of a centralised laboratory 144
RNA-Based Assay for Next-Generation Sequencing of Clinically Relevant Gene Fusions in Non-Small Cell Lung Cancer 142
Moving towards a local testing solution for undetermined thyroid fine-needle aspirates: validation of a novel custom DNA-based NGS panel 142
Evaluation of BRAF, RAS, RET/PTC, and PAX8/PPARg alterations in different Bethesda diagnostic categories: A multicentric prospective study on the validity of the 7-gene panel test in 1172 thyroid FNAs deriving from different hospitals in South Italy 140
EGFR mutation detection on lung cancer cytological specimens by the novel fully automated PCR-based Idylla EGFR Mutation Assay 138
A challenging case of enteric-type lung adenocarcinoma metastatic to the thyroid harboring RET-fusion diagnosed on fine-needle aspiration 137
Herbal hepatotoxicity: a case of difficult interpretation. 137
Multiplex digital colour-coded barcode technology on RNA extracted from routine cytological samples of patients with non-small cell lung cancer: pilot study 137
UbcH10 overexpression in human lung carcinomas and its correlation with EGFR and p53 mutational status. 135
Development of a gene panel for next-generation sequencing of clinically relevant mutations in cell-free DNA from cancer patients 135
Consistency and reproducibility of next-generation sequencing in cytopathology: A second worldwide ring trial study on improved cytological molecular reference specimens 135
Performance of EGFR mutant-specific antibodies in different cytological preparations: a validation study 134
Ion Torrent next-generation sequencing for routine identification of clinically relevant mutations in colorectal cancer patients 134
The continuing role of breast fine-needle aspiration biopsy after the introduction of the IAC Yokohama System For Reporting Breast Fine Needle Aspiration Biopsy Cytopathology 134
CD10 is useful to identify gastrointestinal contamination in endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) cytology from pancreatic ductal adenocarcinoma. 132
Next generation sequencing in cytology 132
KRAS mutations testing in non-small cell lung cancer: The role of Liquid biopsy in the basal setting 131
Pure primary squamous cell carcinoma of the breast presenting as an intracystic tumor. 130
Predictive molecular pathology in the time of COVID-19 130
Methods for actionable gene fusion detection in lung cancer: now and in the future 130
Liquid Biopsy in Prostate Cancer Management{\textemdash}Current Challenges and Future Perspectives 129
SANGER SEQUENCING IN ROUTINE KRAS TESTING: AREVIEW OF 1720 CASES FROM A PATHOLOGIST’SPERSPECTIVE 129
EGFR mutation detection by microfluidic technology: a validation study. 129
The evolving role of interventional cytopathology from thyroid FNA to NGS: Lessons learned at Federico II University of Naples 128
RNA-Based Next-Generation Sequencing in Non-Small Cell Lung Cancer patients: data from Campania, Italy 127
A novel approach to classification and reporting of lymph node fine-needle cytology: Application of the proposed sydney system 127
Brca1/2 ngs somatic testing in clinical practice: a short report 127
There is still a role for cytology in the 'liquid biopsy' era. A lesson from a TKI-treated patient showing adenocarcinoma to squamous cell carcinoma transition during disease progression 126
Is the Idylla EGFR Mutation Assay feasible on archival stained cytological smears? A pilot study 125
Evaluation of Micro Satellite Instability and Mismatch Repair Status in Different Solid Tumors: A Multicenter Analysis in a Real World Setting 124
How Molecular and Ancillary Tests Can Help in Challenging Cytopathology Cases: Insights from the International Molecular Cytopathology Meeting 122
KRAS detection on archival cytological smears by the novel fully automated polymerase chain reaction-based Idylla mutation test 122
Interventional cytopathologist perspective on the Milan System Classification: a study on 929 consecutive salivary gland fine-needle aspirations with a focus on challenging diagnostic categories 121
UbcH10 overexpression is less pronounced in older colorectal cancer patients 121
Thyroid fine-needle aspiration trends before, during, and after the lockdown: what we have learned so far from the COVID-19 pandemic 121
Multiple predictive biomarker testing in melanoma: another challenge for the optimal approach on cytological samples 120
EGFR mutation detection on routine cytological smears of non-small cell lung cancer by digital PCR: A validation study 120
KRAS testing in metastatic colorectal carcinoma: challenges, controversies, breakthroughs, and beyond 119
Fully automated PCR detection of KRAS mutations on pancreatic endoscopic ultrasound fine-needle aspirates 119
Biopsic Sampling (cancer) comprehensive sampling and sample preparation 118
EGFR mutant allelic-specific imbalance assessment in routine samples of non-small cell lung cancer 118
Less frequently mutated genes in colorectal cancer: Evidences from next-generation sequencing of 653 routine cases 118
Applications and limitations of oncogene mutation testing in clinical cytopathology. 117
PD-L1 and beyond: Immuno-oncology in cytopathology 117
Evaluating local thyroid cytopathology practices by molecular quality metrics: A multi‐institutional study on 4651 FNAs with a focus on the role of the interventional cytopathologist 117
Is the Isthmus Location an Additional Risk Factor for Indeterminate Thyroid Nodules? Case Report and Review of the Literature. 116
Interobserver variability in cytopathology: How much do we agree? 115
How should a follicular adenoma with papillary architecture be classified on thyroid FNA? Case report with histological correlation 115
How to prepare cytological samples for molecular testing 115
KRAS mutation detection by high resolution melting analysis significantly predicts clinical benefit of cetuximab in metastatic colorectal cancer 114
Next-Generation Sequencing of Lung Cancer EGFR Exons 18-21 Allows Effective Molecular Diagnosis of Small Routine Samples (Cytology and Biopsy). 114
Fine-Needle Aspiration Is Suitable for Breast Cancer BRCA Molecular Assessment: A Case Report 114
EGFR exon 19 deletion switch and development of p.L792Q mutation as a new resistance mechanism to osimertinib: A case report and literature review 113
Microfluidic chip technology applied to fine-needle aspiration cytology samples for IGH clonality assessment 113
Impact assessment of the implementation of an integrated care model for thyroid disease at the university hospital “federico ii” of naples (Campania region, southern italy): An interrupted time series analysis 113
Microsatellite instability evaluation of patients with solid tumour: routine practice insight from a large series of Italian referral centre 113
PAX8 is expressed in anaplastic thyroid carcinoma diagnosed by fine-needle aspiration: a study of three cases with histological correlates. 112
Cytological and Molecular Features of PapillaryThyroid Carcinoma with Prominent Hobnail Features:A Case Report 111
EGFR analysis: Current evidence and future directions 111
Foamy gland pancreatic ductal adenocarcinoma diagnosed on EUS-FNA: A histochemical, immunohistochemical, and molecular report 109
Multicentric encapsulated papillary oncocytic neoplasm of the thyroid: A case diagnosed by a combined cytological, histological, immunohistochemical, and molecular approach 108
Interventional cytopathologist can successfully combine ultrasonographical and microscopic skills to narrow the differential diagnosis in fine‐needle aspiration of neck paraganglioma 107
Young investigator challenge: Can the Ion AmpliSeq Cancer Hotspot Panel v2 be used for next-generation sequencing of thyroid FNA samples? 107
Kras Testing On Cytologic Imprints of Colo-rectal Carcinoma 105
Cytologically undetermined follicular lesions: surgical procedures and histological outcome in 472 cases. 104
MicroRNA profiling predicts positive nodal status in papillary thyroid carcinoma in the preoperative setting 103
Bird's eye view of modern cytopathology: Report from the seventh international Molecular Cytopathology Meeting in Naples, Italy, 2018 103
COVID-19 pandemic impact on cytopathology practice in the post-lockdown period: An international, multicenter study 103
Navigating the Diagnostic Challenges in Lymph Node Cytology: The Case of Reactive Hyperplasia 102
Molecular testing in salivary gland cytopathology: A practical overview in conjunction with the Milan system 101
EGFR and KRAS mutations detection on lung cancer liquid-based cytology: a pilot study 101
Totale 13.344
Categoria #
all - tutte 57.213
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.213


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022742 0 13 8 11 9 16 14 43 78 63 172 315
2022/20231.101 131 56 41 83 142 118 5 118 201 123 65 18
2023/2024730 39 137 91 48 30 50 6 88 23 33 106 79
2024/20254.420 199 235 8 23 114 213 437 272 284 560 1.706 369
2025/20268.701 877 565 870 737 1.476 395 1.124 434 1.057 616 288 262
2026/2027380 163 217 0 0 0 0 0 0 0 0 0 0
Totale 17.161